Key result
Cardiac positron emission tomography is a highly accurate gold standard for assessing myocardial viability, identifying patients with ischemic cardiomyopathy who will benefit most from revascularization.
Population
Patients with poor left ventricular function and ischemic heart disease being considered for…
Design
Review
Authors
Loading...
Supports PET viability imaging in ischemic cardiomyopathy; leaves open randomized confirmation of revascularization benefit.
Cardiac PET is a highly accurate, non-invasive imaging modality for assessing myocardial viability, which is crucial for identifying patients with ischemic cardiomyopathy who will benefit most from revascularization.
FYJ Keng (2004) conducted a review in Ischemic heart disease with depressed left ventricular function. Cardiac Positron Emission Tomography (PET) was evaluated. Cardiac positron emission tomography is a highly accurate gold standard for assessing myocardial viability, identifying patients with ischemic cardiomyopathy who will benefit most from revascularization.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: